J. Carter, Blair Weaver, M. Chiacchio, Amy R. Messersmith, W. Lynch, Brent D. Feske, G. Gumina
{"title":"一种可能无肾毒性的3 ' - c -乙酰肼嘌呤霉素类似物的合成、立体化学表征和抗菌评价","authors":"J. Carter, Blair Weaver, M. Chiacchio, Amy R. Messersmith, W. Lynch, Brent D. Feske, G. Gumina","doi":"10.1080/15257770.2016.1264590","DOIUrl":null,"url":null,"abstract":"GRAPHICAL ABSTRACT ABSTRACT Puromycin is a peptidyl nucleoside endowed with significant antibiotic and anticancer properties, but also with an unfortunate nephrotoxic character that has hampered its use as a chemotherapeutic agent. Since hydrolysis of puromycin's amide to puromycin aminonucleoside is the first metabolic step leading to nephrotoxicity, we designed a 3′-C-hydrazide analog where the nitrogen and carbon functionality around the amide carbonyl of puromycin are inverted. The title compound, synthesized in 11 steps from D-xylose, cannot be metabolized to the nephrotoxic aminonucleoside. Evaluation of the title compound on Staphylococcus epidermidis and multi-drug resistance Staphylococcus aureus did not show significant antimicrobial activity up to a 400 μM concentration.","PeriodicalId":19306,"journal":{"name":"Nucleosides, Nucleotides and Nucleic Acids","volume":"9 6 1","pages":"224 - 241"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Synthesis, stereochemical characterization, and antimicrobial evaluation of a potentially nonnephrotoxic 3′-C-acethydrazide puromycin analog\",\"authors\":\"J. Carter, Blair Weaver, M. Chiacchio, Amy R. Messersmith, W. Lynch, Brent D. Feske, G. Gumina\",\"doi\":\"10.1080/15257770.2016.1264590\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"GRAPHICAL ABSTRACT ABSTRACT Puromycin is a peptidyl nucleoside endowed with significant antibiotic and anticancer properties, but also with an unfortunate nephrotoxic character that has hampered its use as a chemotherapeutic agent. Since hydrolysis of puromycin's amide to puromycin aminonucleoside is the first metabolic step leading to nephrotoxicity, we designed a 3′-C-hydrazide analog where the nitrogen and carbon functionality around the amide carbonyl of puromycin are inverted. The title compound, synthesized in 11 steps from D-xylose, cannot be metabolized to the nephrotoxic aminonucleoside. Evaluation of the title compound on Staphylococcus epidermidis and multi-drug resistance Staphylococcus aureus did not show significant antimicrobial activity up to a 400 μM concentration.\",\"PeriodicalId\":19306,\"journal\":{\"name\":\"Nucleosides, Nucleotides and Nucleic Acids\",\"volume\":\"9 6 1\",\"pages\":\"224 - 241\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nucleosides, Nucleotides and Nucleic Acids\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/15257770.2016.1264590\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nucleosides, Nucleotides and Nucleic Acids","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15257770.2016.1264590","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
摘要:嘌呤霉素是一种肽基核苷,具有显著的抗生素和抗癌特性,但也具有不幸的肾毒性,这阻碍了它作为化疗药物的使用。由于嘌呤霉素酰胺水解为嘌呤霉素氨基核苷是导致肾毒性的第一个代谢步骤,我们设计了一个3 ' - c -肼类似物,其中嘌呤霉素酰胺羰基周围的氮和碳官能团被倒置。标题化合物由d -木糖经11步合成,不能代谢为肾毒性氨基核苷。在400 μM浓度下对表皮葡萄球菌和耐多药金黄色葡萄球菌的抑菌活性不显著。
Synthesis, stereochemical characterization, and antimicrobial evaluation of a potentially nonnephrotoxic 3′-C-acethydrazide puromycin analog
GRAPHICAL ABSTRACT ABSTRACT Puromycin is a peptidyl nucleoside endowed with significant antibiotic and anticancer properties, but also with an unfortunate nephrotoxic character that has hampered its use as a chemotherapeutic agent. Since hydrolysis of puromycin's amide to puromycin aminonucleoside is the first metabolic step leading to nephrotoxicity, we designed a 3′-C-hydrazide analog where the nitrogen and carbon functionality around the amide carbonyl of puromycin are inverted. The title compound, synthesized in 11 steps from D-xylose, cannot be metabolized to the nephrotoxic aminonucleoside. Evaluation of the title compound on Staphylococcus epidermidis and multi-drug resistance Staphylococcus aureus did not show significant antimicrobial activity up to a 400 μM concentration.